Previous Article | Next Article ![]()
Molecular and Cellular Biology, August 2001, p. 5566-5576, Vol. 21, No. 16
Departments of Medicine, Microbiology, and
Immunology, Howard Hughes Medical Institute, University of
California, San Francisco, California 94143-0703
Received 25 January 2001/Returned for modification 23 March
2001/Accepted 10 May 2001
Ankyrin repeats are well-known structural modules that mediate
interactions between a wide spectrum of proteins. The regulatory factor
X with ankyrin repeats (RFXANK) is a subunit of a tripartite RFX
complex that assembles on promoters of major histocompatibility complex
class II (MHC II) genes. Although it is known that RFXANK plays a
central role in the nucleation of RFX, it was not clear how its ankyrin
repeats mediate the interactions within the complex and with other
proteins. To answer this question, we modeled the RFXANK protein and
determined the variable residues of the ankyrin repeats that should
contact other proteins. Site-directed alanine mutagenesis of these
residues together with in vitro and in vivo binding studies elucidated
how RFXAP and CIITA, which simultaneously interact with RFXANK in vivo,
bind to two opposite faces of its ankyrin repeats. Moreover, the
binding of RFXAP requires two separate surfaces on RFXANK. One of them,
which is located in the ankyrin groove, is severely affected in the
FZA patient with the bare lymphocyte syndrome. This genetic
disease blocks the expression of MHC II molecules on the surface of B
cells. By pinpointing the interacting residues of the ankyrin repeats
of RFXANK, the mechanism of this subtype of severe combined
immunodeficiency was revealed.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.16.5566-5576.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Analysis of Ankyrin Repeats Reveals How a Single Point
Mutation in RFXANK Results in Bare Lymphocyte Syndrome
*
Corresponding author. Mailing address: Room N215, UCSF
Mt. Zion Cancer Center, 2340 Sutter St., San Francisco, CA 94115. Phone: (415) 502-1902. Fax: (415) 502-1901. E-mail:
matija{at}itsa.ucsf.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|